|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2-Aminopyridine | CAS 504-29-0 | ||
| NH2C5H4N | RTECS US1575000 | ||
|
Synonyms & Trade Names alpha-Aminopyridine, alpha-Pyridylamine |
DOT ID & Guide 2671 153 |
||
|
Exposure Limits |
NIOSH REL: TWA 0.5 ppm (2 mg/m3) | ||
| OSHA PEL: TWA 0.5 ppm (2 mg/m3) | |||
| IDLH 5 ppm See: 504290 | Conversion 1 ppm = 3.85 mg/m3 | ||
|
Physical Description White powder, leaflets, or crystals with a characteristic odor. |
|||
|
MW: 94.1 |
BP: 411°F |
MLT: 137°F |
Sol: >100% |
|
VP(77°F): 0.8 mmHg |
IP: 8.00 eV |
|
Sp.Gr: ? |
|
Fl.P: 154°F |
UEL: ? |
LEL: ? |
|
| Combustible Solid | |||
|
Incompatibilities & Reactivities Strong oxidizers |
|||
|
Measurement Methods NIOSH S158 (II-4) See: NMAM or OSHA Methods |
|
Personal Protection & Sanitation Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated Remove: When wet or contaminated Change: Daily Provide: Quick drench |
First Aid (See procedures) Eye: Irrigate immediately Skin: Water flush immediately Breathing: Respiratory support Swallow: Medical attention immediately |
|
Important additional information about respirator selection Respirator Recommendations NIOSH/OSHA Up to 5 ppm: (APF = 10) Any supplied-air respirator*/(APF = 50) Any self-contained breathing apparatus with a full facepiece Emergency or planned entry into unknown concentrations or IDLH conditions: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode/(APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister having a high-efficiency particulate filter/Any appropriate escape-type, self-contained breathing apparatus |
|
| Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact | |
| Symptoms Irritation eyes, nose, throat; headache, dizziness; excitement; nausea; high blood pressure; respiratory distress; lassitude (weakness, exhaustion); convulsions; stupor | |
|
Target Organs
central nervous system, respiratory system |
|
| See also: INTRODUCTION See ICSC CARD: 0214 |